TherapeuticsMD, Inc.
TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects includeā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$2.03
Price0.00%
$0.00
1Y
Price
Market Cap
$23.496m
Small
Price/Earnings 3y Avg5y Avg
103.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+19.0%
EBITDA Margin+19.4%
Net Profit Margin+133.4%
Free Cash Flow Margin+19.0%
EBITDA Margin+19.4%
Net Profit Margin+133.4%
Free Cash Flow MarginRevenue
$3.353m
+58.8%
1y CAGR-1.4%
3y CAGR+653.8%
5y CAGREarnings
$179k
+113.8%
1y CAGR+27.8%
3y CAGR+62.1%
5y CAGREPS
$0.02
+110.5%
1y CAGR+92.6%
3y CAGR+84.4%
5y CAGRBook Value
$26.973m
$37.581m
Assets$10.608m
Liabilities$5.831m
DebtDebt to Assets
15.5%
-6.7x
Debt to EBITDAFree Cash Flow
$2.674m
+182.5%
1y CAGR+94.2%
3y CAGR+94.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company